COVID-19 vaccines: keeping pace with SARS-CoV-2 variants

Muge Cevik, Nathan D. Grubaugh, Akiko Iwasaki, Peter Openshaw

Research output: Contribution to journalComment/debate

92 Citations (Scopus)


As the SARS-CoV-2 pandemic evolves, new variants continue to emerge. Some highly transmissible variants, such as Delta, also raised concerns about the effectiveness provided by current vaccines. Understanding immunological correlates of protection and how laboratory findings correspond to clinical effectiveness is imperative to shape future vaccination strategies.
Original languageEnglish
Publication statusPublished - 16 Sept 2021


  • COVID-19


Dive into the research topics of 'COVID-19 vaccines: keeping pace with SARS-CoV-2 variants'. Together they form a unique fingerprint.

Cite this